Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Goodman

Showing results (891-900 of 1,119) with videos related to

Pageof 112
Sort By:
JAMA|November 24, 2005
High-risk patients with acute coronary syndromes treated with low-molecular-weight or unfractionated heparin: outcomes at 6 months and 1 year in the SYNERGY trialKenneth W Mahaffey, Marc Cohen, Jyotsna Garg, et al.
Circulation|December 21, 2018
Antithrombotic Therapy in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Undergoing Percutaneous Coronary Intervention: A North American Perspective-2018 UpdateDominick J Angiolillo, Shaun G Goodman, Deepak L Bhatt, et al.
Plos Pathogens|May 23, 2009
P58(IPK): a novel "CIHD" member of the host innate defense response against pathogenic virus infectionAlan G Goodman, Jamie L Fornek, Guruprasad R Medigeshi, et al.
American Heart Journal|March 30, 2013
Clinical outcomes and cost implications of routine early PCI after fibrinolysis: one-year follow-up of the Trial of Routine Angioplasty and Stenting after Fibrinolysis to Enhance Reperfusion in Acute Myocardial Infarction (TRANSFER-AMI) studyAkshay Bagai, Warren J Cantor, Mary Tan, et al.
European Heart Journal|May 25, 2026
Interleukin-6 and C-reactive protein prognostic value following acute coronary syndromeJohan Wouter Jukema, Nicolaas J Van Neer, Michael Szarek, et al.
Cardiovascular Diabetology|October 5, 2021
Impact of empagliflozin on right ventricular parameters and function among patients with type 2 diabetesBradley Sarak, Subodh Verma, C David Mazer, et al.
BMJ Open|December 18, 2023
Comparing the long-term outcomes in chronic coronary syndrome patients with prior ST-segment and non-ST-segment elevation myocardial infarction: findings from the TIGRIS registrySibi N Krishnamurthy, Stuart Pocock, Prashant Kaul, et al.
European Heart Journal|September 12, 2018
Guideline-indicated treatments and diagnostics, GRACE risk score, and survival for non-ST elevation myocardial infarctionMarlous Hall, Owen J Bebb, Tatandashe B Dondo, et al.
The Canadian Journal of Cardiology|June 16, 2010
Treatment gaps in the management of cardiovascular risk factors in patients with type 2 diabetes in CanadaManoela Braga, Amparo Casanova, Hwee Teoh, et al.
The American Journal of Medicine|June 14, 2024
Antithrombotic Strategies According to Age: Insights from the AUGUSTUS TrialPatricia O Guimarães, Renato D Lopes, Daniel M Wojdyla, et al.
Pageof 112

Showing results (891-900 of 1,119) with videos related to

Sort By:
Pageof 112
JAMA|November 24, 2005
High-risk patients with acute coronary syndromes treated with low-molecular-weight or unfractionated heparin: outcomes at 6 months and 1 year in the SYNERGY trialKenneth W Mahaffey, Marc Cohen, Jyotsna Garg, et al.
Circulation|December 21, 2018
Antithrombotic Therapy in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Undergoing Percutaneous Coronary Intervention: A North American Perspective-2018 UpdateDominick J Angiolillo, Shaun G Goodman, Deepak L Bhatt, et al.
Plos Pathogens|May 23, 2009
P58(IPK): a novel "CIHD" member of the host innate defense response against pathogenic virus infectionAlan G Goodman, Jamie L Fornek, Guruprasad R Medigeshi, et al.
American Heart Journal|March 30, 2013
Clinical outcomes and cost implications of routine early PCI after fibrinolysis: one-year follow-up of the Trial of Routine Angioplasty and Stenting after Fibrinolysis to Enhance Reperfusion in Acute Myocardial Infarction (TRANSFER-AMI) studyAkshay Bagai, Warren J Cantor, Mary Tan, et al.
European Heart Journal|May 25, 2026
Interleukin-6 and C-reactive protein prognostic value following acute coronary syndromeJohan Wouter Jukema, Nicolaas J Van Neer, Michael Szarek, et al.
Cardiovascular Diabetology|October 5, 2021
Impact of empagliflozin on right ventricular parameters and function among patients with type 2 diabetesBradley Sarak, Subodh Verma, C David Mazer, et al.
BMJ Open|December 18, 2023
Comparing the long-term outcomes in chronic coronary syndrome patients with prior ST-segment and non-ST-segment elevation myocardial infarction: findings from the TIGRIS registrySibi N Krishnamurthy, Stuart Pocock, Prashant Kaul, et al.
European Heart Journal|September 12, 2018
Guideline-indicated treatments and diagnostics, GRACE risk score, and survival for non-ST elevation myocardial infarctionMarlous Hall, Owen J Bebb, Tatandashe B Dondo, et al.
The Canadian Journal of Cardiology|June 16, 2010
Treatment gaps in the management of cardiovascular risk factors in patients with type 2 diabetes in CanadaManoela Braga, Amparo Casanova, Hwee Teoh, et al.
The American Journal of Medicine|June 14, 2024
Antithrombotic Strategies According to Age: Insights from the AUGUSTUS TrialPatricia O Guimarães, Renato D Lopes, Daniel M Wojdyla, et al.
Pageof 112